FerTech startup Luma Fertility has secured $4 million in seed funding, led by Peak XV’s Surge, with additional backing from healthcare veteran Ameera Shah (of Metropolis Healthcare) and investor Vijay Taparia of B2V Ventures.
Founded by serial entrepreneur Neha K. Motwani, Luma aims to revolutionize fertility care in India by infusing the process with technology, transparency, and empathy—an effort to modernize an experience often viewed as stressful and unclear.
Motwani, who previously built the fitness platform Fitternity and led it to acquisition by Cult.fit in 2021, now focuses on a highly personal and underserved domain: fertility. With India’s fertility rate dropping below replacement levels (from 2.1 to 1.9) and IVF cycles expected to rise from 320,000 in 2024 to 550,000 by 2028, the sector presents significant opportunity for innovation.
The fresh funding will not only support Luma’s expansion within Mumbai—where it recently launched a 6,000 sq ft tech-enabled flagship clinic in Bandra—but also facilitate its entry into additional Indian cities over the next two years.
“We’re not just another IVF clinic,” said Motwani. “We’re building a platform that supports individuals and couples through every step of their fertility journey—with compassion, science, and digital innovation at its core.”
Luma Fertility provides end-to-end fertility services, including IVF, egg and embryo freezing, fertility assessments, and pre-conception care. The startup truly distinguishes itself with its tech-driven model, centering on an IVF companion app that delivers real-time updates, tracks the patient journey, and offers LumaAI—a 24/7 virtual assistant providing cycle guidance and medication support.
In addition to clinical treatments, Luma integrates holistic wellness offerings such as nutrition counseling, acupuncture, IV therapy, and at-home semen testing, making fertility care more approachable and less intimidating.
Luma designed its flagship clinic in Bandra to foster transparency and trust, featuring an open lab layout and assigning a dedicated care team to each patient—key elements in a field often criticized for lacking clarity and empathy.
Looking ahead, Luma is focusing on the rapidly growing segment of egg and embryo freezing, especially among urban millennials and Gen Z who are choosing to delay parenthood.
By combining technology, transparency, and personalized care, Luma Fertility is well-positioned to redefine the fertility experience in India.
